HomePTIX • NASDAQ
Follow
Protagenic Therapeutics Inc
Previous close
$1.35
Day range
$1.41 - $1.56
Year range
$0.68 - $2.32
Market cap
6.30M USD
Avg Volume
12.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.21M | 84.85% |
Net income | -1.68M | -178.73% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.19M | -80.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.06M | -49.16% |
Total assets | 4.32M | -46.21% |
Total liabilities | 655.25K | -41.49% |
Total equity | 3.67M | — |
Shares outstanding | 4.44M | — |
Price to book | 1.63 | — |
Return on assets | -62.13% | — |
Return on capital | -73.55% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.68M | -178.73% |
Cash from operations | -1.14M | -532.51% |
Cash from investing | 2.28M | 1,308.25% |
Cash from financing | — | — |
Net change in cash | 1.13M | 1,895.15% |
Free cash flow | -901.12K | -1,618.88% |
About
Founded
1994
Website
Employees
2